Immunologists struggling to understand COVID-19 are in it for the long haul

Researchers are conducting the first long-term prospective study to understand the immune response to COVID-19 long after initial infection.

Natalya Ortolano, PhD Headshot
Aug 19, 2021
Natalya Ortolano, PhD

Natalya received her PhD in from Vanderbilt University in 2021; she joined the DDN team the same week she defended her thesis. Her work has been featured at STAT News,...

View full profile.


Learn about our editorial policies.

COVID-19 severity is extremely variable between patients. Some patients experience extreme shortness of breath, require ventilation, and even die from the infection while other patients feel like they have a mild cold. This variable immune response seems to continue after a patient fights off the initial infection causing long term symptoms like brain fog, extreme fatigue, and heart problems. Researchers across institutions are tracking the immune response of patients a year after their first possible test to understand how COVID-19 impacts the immune system long-term and identify biomarkers to predict who will experience severe infection and long-term symptoms.

Download the COVID Long Haul infographic here

Illustration by Ashleigh Campsall 
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

DDN June 2022 magazine issue front cover

Latest Issue  

• Volume 18 • Issue 6 • June 2022

June 2022

June 2022 Issue